… problem in some patients, particularly elderly patients, patients taking concomitant oral
glucocorticoids, immunosuppressants, or antibiotics, and patients inhaling glucocorticoids at high …

… Initiation of inhaled glucocorticoids at a young age has potential effects on bone accrual,
peak bone mass, and growth in addition to the cumulative lifetime effects of these medications. …

… with inhaled glucocorticoid use but … of inhaled glucocorticoid treatment. Possible explanations
for this, with reference to the pharmacology and molecular mechanisms of glucocorticoid …

… of posterior subcapsular cataracts in patients taking inhaled glucocorticoids, based on
our sample, is as high as previously estimated in patients taking oral glucocorticoids …

… Long term effect of oral and inhaled glucocorticoids on bone mass in chronic asthma. A two
… Growth and adrenal responsiveness in young asthmatic children on inhaled corticosteroids […

… when the inhaled glucocorticoids were withdrawn. Inhaled glucocorticoids are also effective
in even younger children. For example, nebulized budesonide reduced the need for oral …

… inhaled glucocorticoids to the airways in young children; large-volume (750 mL) spacer
devices are preferable in older children. Metered-dose inhalers containing hydrofluoroalkane (…

… The use of inhaled glucocorticoids for persistent asthma causes a temporary reduction in …
after the initiation of inhaled glucocorticoids is thought not to decrease attained adult height. …

… early inhaled glucocorticoid therapy in premature infants at risk for bronchopulmonary
dysplasia is associated with a lower rate of subsequent therapy with systemic glucocorticoids and …

… younger than 6 years received one quarter of that dose. Suspensions of inhaled glucocorticoids
for … Although nebulizers are often used to deliver aerosols to young children to avoid the …